Louisiana State Employees Retirement System trimmed its position in shares of Humana Inc. (NYSE:HUM – Free Report) by 1.5% in the 2nd quarter, Holdings Channel reports. The institutional investor owned 6,400 shares of the insurance provider’s stock after selling 100 shares during the quarter. Louisiana State Employees Retirement System’s holdings in Humana were worth $1,565,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds also recently bought and sold shares of HUM. Revolve Wealth Partners LLC purchased a new position in Humana during the fourth quarter worth $202,000. GAMMA Investing LLC boosted its stake in shares of Humana by 54.9% during the first quarter. GAMMA Investing LLC now owns 2,952 shares of the insurance provider’s stock valued at $781,000 after purchasing an additional 1,046 shares during the period. Assenagon Asset Management S.A. boosted its stake in shares of Humana by 8.2% during the first quarter. Assenagon Asset Management S.A. now owns 5,378 shares of the insurance provider’s stock valued at $1,423,000 after purchasing an additional 409 shares during the period. CX Institutional purchased a new stake in shares of Humana during the first quarter valued at $213,000. Finally, Fifth Third Bancorp boosted its stake in shares of Humana by 14.4% during the first quarter. Fifth Third Bancorp now owns 8,228 shares of the insurance provider’s stock valued at $2,177,000 after purchasing an additional 1,034 shares during the period. 92.38% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes
HUM has been the subject of a number of recent analyst reports. Piper Sandler lowered their target price on shares of Humana from $288.00 to $272.00 and set a “neutral” rating for the company in a research note on Thursday, July 31st. Wall Street Zen lowered shares of Humana from a “buy” rating to a “hold” rating in a research note on Saturday, August 2nd. Royal Bank Of Canada boosted their target price on shares of Humana from $283.00 to $322.00 and gave the company an “outperform” rating in a research note on Thursday, August 21st. Evercore ISI initiated coverage on shares of Humana in a research note on Monday, September 22nd. They set an “in-line” rating and a $295.00 target price for the company. Finally, Wells Fargo & Company boosted their target price on shares of Humana from $344.00 to $347.00 and gave the company an “overweight” rating in a research note on Tuesday, October 7th. Eight equities research analysts have rated the stock with a Buy rating, ten have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $298.83.
Humana Stock Down 3.6%
NYSE:HUM opened at $280.24 on Monday. Humana Inc. has a 1-year low of $206.87 and a 1-year high of $315.35. The company has a 50-day moving average of $279.45 and a 200 day moving average of $258.04. The firm has a market cap of $33.71 billion, a PE ratio of 21.51, a price-to-earnings-growth ratio of 1.64 and a beta of 0.42. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.95 and a quick ratio of 1.95.
Humana (NYSE:HUM – Get Free Report) last released its quarterly earnings data on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share for the quarter, missing analysts’ consensus estimates of $6.32 by ($0.05). Humana had a return on equity of 13.67% and a net margin of 1.28%.The business had revenue of $32.39 billion during the quarter, compared to analysts’ expectations of $31.85 billion. During the same period last year, the company earned $6.96 earnings per share. The firm’s revenue was up 9.6% compared to the same quarter last year. Humana has set its FY 2025 guidance at 17.000- EPS. As a group, research analysts anticipate that Humana Inc. will post 16.47 EPS for the current fiscal year.
Humana Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be issued a $0.885 dividend. The ex-dividend date is Friday, September 26th. This represents a $3.54 dividend on an annualized basis and a yield of 1.3%. Humana’s payout ratio is currently 27.17%.
Humana Profile
Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
Further Reading
- Five stocks we like better than Humana
- Golden Cross Stocks: Pattern, Examples and Charts
- Microsoft 365 Premium Marks the Next Phase of AI Monetization
- The How And Why of Investing in Oil Stocks
- Could Target’s Week of Discounts Come Full Circle for Investors?
- Quiet Period Expirations Explained
- 3 Reasons to Buy Sprouts Farmers Market Ahead of Earnings
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM – Free Report).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.